Recovery
Thymosin Alpha-1
Research listing. Not an approved medicine.
An immune-modulating peptide studied for immune responses, certain infections, and supportive treatment in selected medical conditions. Approval and evidence vary by country and indication.
Vial size
CA$83
Estimated retail midpoint, CAD
Research-use only. Not for human or veterinary administration. Availability depends on applicable regulations, including in Canada. Prices are estimates, not verified market averages. Descriptions are informational and do not imply Health Canada approval or proven clinical effectiveness. Many listed compounds are investigational or not authorized for human use in Canada.